Literature DB >> 11177145

Total mesorectal excision and low rectal anastomosis for the treatment of rectal cancer and prevention of pelvic recurrences.

A Tocchi1, G Mazzoni, L Lepre, G Liotta, G Costa, N Agostini, M Miccini, L Scucchi, G Frati, S Tagliacozzo.   

Abstract

HYPOTHESIS: Total mesorectal excision lowers the rate of pelvic recurrence and positively affects the survival after surgical treatment of rectal cancer.
DESIGN: Case series.
SETTING: Tertiary care university hospital. PATIENTS: Fifty-three consecutive patients were admitted with curative intent to surgery at the First Department of Surgery of the University of Rome "La Sapienza," Rome, Italy, with diagnoses of rectal carcinoma. The mean follow-up was 68.9 months; follow-up was complete for all patients who entered the trial.
INTERVENTIONS: Low anterior resection and total mesorectal excision were performed in all cases, regardless of the location of the rectal cancer. A straight mechanical colorectal anastomosis was performed on a rectal stump, never exceeding 5 cm. No kind of adjuvant therapy was given. Mesorectum and open rectum were studied by serial transverse section at 5-mm intervals. A search for depth of penetration and distal intramural extension of the tumor was made. Lymph nodes were detected by clearing method, and nodal metastases (NM) and nonnodal metastases (NNM) were recorded as situated proximally, distally, or at the level of the tumor.
RESULTS: There was no postoperative mortality. Clinical and radiologic leaks occurred in 2 and 4 patients, respectively. Mean disease-free survival was 65.9 months. Pelvic recurrence occurred in 5 patients (9%). Overall 5-year survival rate was 75%. Involvement of mesorectum by NM and NNM was detected in 27 and 24 cases, respectively. Both NM and NNM were found to be distal in 33% and 40% of cases, respectively.
CONCLUSIONS: Microscopic spread to the distal mesorectum may exceed the intramural spread of rectal cancer. Failure to perform total mesorectal excision leaves a potentially residual disease in the distal mesorectum, thus predisposing the patient to pelvic recurrence.

Entities:  

Mesh:

Year:  2001        PMID: 11177145     DOI: 10.1001/archsurg.136.2.216

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  21 in total

1.  Total mesorectal excision for rectal cancer: the truth lies underneath.

Authors:  Jesús A Fernández-Represa; Julio M Mayol; Julio Garcia-Aguilar
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

2.  Laparoscopic total mesorectal excision of low rectal cancer with preservation of anal sphincter: a report of 82 cases.

Authors:  Zong-Guang Zhou; Zhao Wang; Yong-Yang Yu; Ye Shu; Zhong Cheng; Li Li; Wen-Zhang Lei; Tian-Cai Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 3.  Total Mesorectal Excision Technique-Past, Present, and Future.

Authors:  Joep Knol; Deborah S Keller
Journal:  Clin Colon Rectal Surg       Date:  2020-04-28

4.  Long-term functional outcome of colonic J-pouch reconstruction after low anterior resection for rectal cancer.

Authors:  Jin-Ichi Hida; Takehito Yoshifuji; Kiyotaka Okuno; Tomohiko Matsuzaki; Toshihiro Uchida; Eizaburou Ishimaru; Tadao Tokoro; Masayuki Yasutomi; Hitoshi Shiozaki
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance.

Authors:  Dietrich Doll; Ralf Gertler; Matthias Maak; Jan Friederichs; Karen Becker; Hans Geinitz; Monika Kriner; Hjalmar Nekarda; Jörg R Siewert; Robert Rosenberg
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

Review 6.  Evolving management of colorectal cancer.

Authors:  Jochem van der Voort van Zijp; Harald J Hoekstra; Marc D Basson
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 7.  High ligation of the inferior mesenteric artery in rectal cancer surgery.

Authors:  Jin-Ichi Hida; Kiyotaka Okuno
Journal:  Surg Today       Date:  2012-10-07       Impact factor: 2.549

8.  Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer.

Authors:  Hideki Ueno; Hidetaka Mochizuki; Yojiro Hashiguchi; Keiichi Ishikawa; Hajime Fujimoto; Eiji Shinto; Kazuo Hase
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

9.  Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III.

Authors:  E J Th Belt; M F M van Stijn; H Bril; E S M de Lange-de Klerk; G A Meijer; S Meijer; H B A C Stockmann
Journal:  Ann Surg Oncol       Date:  2010-07-13       Impact factor: 5.344

10.  Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.

Authors:  Wai Lun Law; Kin Wah Chu
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.